New study: Only reliable rapid corona tests make sense
More and more manufacturers are bringing corona rapid tests onto the market. But only if they provide reliable results does their use in the fight against the pandemic makes sense. The Charité hospital in Berlin, one of the largest university hospitals in Europe, has now reviewed the performance of corona antigen rapid tests. The corona rapid test from nal von minden GmbH proved to be particularly reliable. The NADAL® COVID-19 Ag rapid test has already been used millions of times throughout Europe during the corona pandemic and provides a result within only 15 minutes.
Corona rapid tests are playing an increasingly important role. In nursing homes, old people's homes and hospitals, they fulfil an especially important function: infectious people can be detected quickly and other people can be better protected against corona.
But how reliable are the test results? Researchers at the Charité hospital in Berlin, led by virologist Prof. Christian Drosten, have now examined both the specificity and sensitivity of different tests. The specificity provides information on whether all healthy people who have been tested are recognised as healthy. The sensitivity indicates whether all sick people are also recognised as sick.
The NADAL® COVID-19 Ag rapid test from nal von minden GmbH was one of the best three tests evaluated: the specificity was 99.26 percent. In terms of sensitivity, the NADAL® COVID-19 Ag rapid test also scored outstandingly well in the Charité study. Roland Meißner, managing director of nal von minden GmbH: "We are pleased about the confirmation of the very good quality of our rapid test.
"A total of 105 swab samples were analysed with the NADAL® COVID-19 Ag rapid test in the Charité study". The swabs were previously taken from the mouth or nasopharynx of patients, placed in a tube with liquid transport medium and frozen at minus 20 degrees Celsius until the examination. Subsequently, comparative tests were carried out in the laboratory in comparison to PCR.
The Charité's methodology differs slightly from clinical studies conducted by nal von minden GmbH. Tobias Roth, biochemist with a focus on virology: "We use the swabs directly on the antigen test. Charité, on the other hand, put the swabs in a liquid transport medium. As a result, the samples were diluted and the results determined by a different evaluation method".
Press contact:Gabriele Hellwig, +49 40 38 66 24 80, firstname.lastname@example.org
About nal von minden GmbH
Subscribe to releases from nal von minden GmbH
Subscribe to all the latest releases from nal von minden GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from nal von minden GmbH
COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease7.1.2021 13:27:50 CET | Press release
Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes.
Corona rapid test: Celebrate Christmas together without anyone getting infected15.12.2020 14:48:24 CET | Pressemeddelelse
In many places, uncertainty is now mixed in with the anticipation of Christmas: will Christmas be a “super spreader event” as many politicians are warning? “No”, Roland Meissner, the CEO of nal von minden in Moers, Germany is convinced: “you can protect your relatives as best as possible by getting tested for corona beforehand.” There are also tips to minimize the risk of corona during the actual festivities.
nal von minden plans to produce 80 million rapid corona tests per month20.11.2020 11:54:07 CET | Press release
Rapid corona testing is playing an increasingly important role in containing the pandemic everywhere – even though the first vaccines are now in sight. The medical technology company nal von minden GmbH from Moers, Germany, is therefore doubling its production: 40 million rapid antigen tests are already being produced in November. By January, this figure is expected to rise to 80 million – every month!
New: Combined rapid test for Covid-19 and influenza2.11.2020 09:45:56 CET | Press release
Corona numbers are rising, and the next challenge is already in sight: Flu season is beginning. The symptoms can be very similar, but a test can differentiate between influenza and Covid-19. A new combined rapid test can detect coronavirus and influenza viruses simultaneously: The NADAL® COVID-19 Ag+Influenza A/B Test from German medical technology company nal von minden delivers a reliable result in just 15 minutes.
New Covid-19 antigen test: Fast and reliable results in just 15 minutes26.10.2020 09:06:23 CET | Press release
Preventing further spread of the coronavirus and taking pressure off laboratories – it is possible with the NADAL® Covid-19 Antigen Test from Germany. Whether in schools, nursing homes, hospitals, companies, or at the airport or larger events: The result is available in just 15 minutes. The new rapid test from medical technology company nal von minden GmbH is already approved in Europe and is available immediately. The high quality has been repeatedly verified.